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Abstract  
Background: The presence of psychological distress has a negative impact not only on 
cancer patients’ quality of life, but also on the course of the disease, with slower recovery and 
increased morbidity. These issues are of particular importance in melanoma patients (MP), 
who remain at risk of disease progression for many years after diagnosis. 
Objectives: To investigate psychological distress, coping strategies and their possible 
relationships with demographic-clinical features in patients with early-stage melanoma in 
follow-up. The investigation focused in particular on whether the psychological profile was 
different between patients at different melanoma stages.  
Methods: Data of 118 patients with melanoma in Tis-Ia stages (MP Tis-Ia) and 86 patients 
with melanoma in stages Ib-IIa-IIb (MP Ib-II) was recruited and compared by means of a  
cross-sectional design.  
Results: The results evidenced a high percentage of anxiety (25%) and distress 
symptoms (44%), while depressive symptoms seemed less frequent (8%). 
Psychological distress was higher in women than in men, and in patients with a 
higher educational level. Nevertheless, no significant differences between MP_Tis-Ia 
and MP_Ib-II were found. With regard to coping style, the patients in this sample 
adopted predominantly positive and active strategies. Correlational analyses showed 
that maladaptive coping strategies such as behavioral disengagement, denial, self-
distraction and self-blame were most strongly related to increased levels of 
psychological distress.  
Conclusions: The high presence of anxiety and distress symptoms, their relationship, 
and the use of negative coping strategies underline the importance of psychological 
distress screening also in early-stage melanoma patients, including at long-term 
follow-up. 
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 Introduction 
The incidence of cutaneous melanoma, the fastest-growing solid tumor that accounts for 
more than 79% of skin cancer-related deaths, has increased dramatically in the Western world 
[1,2]. In particular, although 5 years’ survival is high with the early stages of melanoma 
(more than 96% in situ and 92% in stage I), the percentage falls drastically to 67% in stage II 
and to 49% in stage III [3,4]. What is more, patients with melanoma remain at risk of disease 
progression for many years [5]. Early diagnosis and continued adherence by the patient to 
follow-up examinations are therefore crucial. 
The presence of psychological distress has a negative impact not only on cancer patients’ 
personal and social quality of life, but also on the course of the disease, with slower recovery 
and increased morbidity [1,6-8]. In particular, distress present at follow-up may interfere with 
preventive behaviours (i.e. using sunscreen or avoiding sunlight) or adherence to prescribed 
therapy and rigorous periodic screening (i.e., regular skin examinations, appointments with 
dermatologists) [5,9]. These issues are of particular importance in melanoma patients (MP), 
who remain at risk of disease progression for many years after diagnosis [10]. Most studies 
on psychological distress in melanoma patients have been conducted on those at advanced 
stages, whereas few have addressed the issue in those at early stages [1,11,12]. 
The present study focused on the psychological distress, the coping strategies and their 
possible relationships with demographic-clinical features of early-stage melanoma patients. 
In addition, investigation focused on whether the psychological profile was different between 
patients at Tis-Ia (MP_Tis-Ia) and Ib-II (MP_Ib-II) melanoma stages. Since MP_Ib-II 
patients have undergone a second, more invasive surgery for sentinel lymph node biopsy and 
are commonly required to submit to a more thorough follow-up examination with more 
radiological analyses, it was hypothesized that the medical follow-up could be more 
distressing for them than for MP_Tis-Ia patients’. 
 Methods 
The present study was conducted by means of a cross-sectional design. Patients consecutively 
attending the Department of Surgical Dermatology at the “Città della Salute e della Scienza” 
Hospital of Turin for dermatologic follow-up examinations and fulfilling the inclusion 
criteria were included in the study. The inclusion criteria were: diagnosis of melanoma in situ 
(stage Tis), in stages Ia, Ib, IIa and IIb, age over 18 and the ability to read and understand 
questionnaires. Of the 208 consecutive patients fulfilling the inclusion criteria, 204 patients 
gave their written consent and were enrolled. The study was approved by the Hospital Ethics 
Committee. 
To evaluate the psychological distress, the Hospital Anxiety and Depression Scale for 
depressive (HADS-D) and anxiety (HADS-A) symptoms and the Distress Thermometer (DT) 
for emotional distress were used [13,14]. The Coping Orientation to Problem Experiences 
Scale-brief version (Brief-COPE) was administered to evaluate: Positive reframing, Self-
distraction, Expression, Instrumental support, Active coping, Denial, Religion, Humour, 
Behavioural-disengagement, Emotional support, Use of alcohol/drugs, Acceptance, Planning 
and Self-blame [15]. 
The analyses were performed using the Statistical Package for Social Science - Version 20 
(SPSS-20). Normal distribution of the continuous variables was evaluated using the 
Kolmogorv-Smirnoff Test. Comparisons between MP_Tis-Ia and MP_Ib-II groups were 
performed using the Chi-Square, the T-test or the Mann-Whitney U-Test appropriately. 
Spearman correlations were used to investigate possible associations. Bonferroni corrections 
were applied.  
Results 
Regarding the socio-demographical features, MP_Tis-Ia and MP_Ib-II groups differed 
significantly only in gender distribution. Contrary to our hypothesis, no statistically 
 significant differences in psychological distress or coping strategies were found between 
MP_Tis-Ia and MP_Ib-II patients (Table 1). From this point on, the two groups were 
analyzed together. 
While only 8.8% of the patients (18/204) showed a clinically relevant level of depressive 
symptoms, 25% (51/204) presented a clinically relevant level of anxiety symptoms and 
44.1% (90/204) showed relevant distress (DT). The mean scores showed that the most-used 
coping strategies were acceptance, active coping, planning and positive reframing; less-used 
strategies were alcohol or drug use, denial and behavioural disengagement (Table 1). No 
significant correlations were found between psychological distress, age and time since 
diagnosis. A statistically significant higher level of depressive (M: 2.76(3.1); W: 3.69(3); 
p=.007), anxiety (M: 4.1(3.5); W: 5.79(4.4); p=.007) and distress (M: 2.97(2.7); W: 
3.94(2.8); p=.013) symptoms was present in women (W) than in men (M) and a significantly 
higher level of distress was found in patients with a higher (H) compared to a low/average 
(L/A educational level (H: 3.79(2.9); L/M: 2.66(2.5); p=.010). Since women were found to 
report higher levels of psychological distress and in order to ensure that patient group 
differences in psychological distress would not be obscured by the sex differences, the 
psychological distress comparisons between MP_Tis-Ia and MP_Ib-II groups were performed 
again for the male and the female sub groups separately. Results confirmed that in both sub 
grops no statistically significant differences in psychological distress were present between 
MP_Tis-Ia and MP_Ib-II patients (all p > .05). 
Correlations analyses (Table 2) showed statistically significant positive correlations between 
“Self-distraction”, “Denial” and “Behavioural-disengagement” and psychological distress 
(HADS-D/-A, DT): the higher the psychological distress, the more frequent the use of these 
coping strategies. In addition, statistically significant positive correlations were found 
between “Self Blame” and both anxiety and DT, and between “Expression” and DT.  
  “Positive reframing”, “Acceptance” and “Planning” showed statistically significant negative 
correlations with depressive symptoms, with higher symptoms in patients using these 
strategies less. Finally, “Acceptance” showed a statistically significant negative correlation 
with anxiety symptoms. 
Discussion 
The Melanoma Guideline strongly recommends lifetime dermatologic surveillance for 
patients with melanoma [10], who remain at risk of disease progression for many years [5]. 
The estimated lifetime risk of developing a second primary melanoma ranges between 4 and 
8%, with a 5-year estimated cumulative risk rising to 11.4% [16,17]. Melanoma could thus be 
considered a chronic life-threatening disease [18]. 
A recent review of the literature highlighted that approximately one-third of melanoma 
patients experience clinically relevant levels of psychological distress around the time of 
diagnosis and treatment [19]. Psychological distress in patients with melanoma may have 
notable personal and family implications for the patients [19]. It has been associated not only 
with lower quality of life, but also with delay in seeking medical advice and decreased 
adherence to post-treatment screening and preventive behaviors, which result in increased 
rates of recurrence and mortality [9]. The majority of these studies, however, did not 
differentiate between different stages, or focused less on the long-term periodic follow-up 
screening. In fact, even though most patients with melanoma perceive this crucial event as 
worthwhile and reassuring, this event may also reactivate cancer-related fears [9]. 
The main finding of the present study is the high prevalence of anxiety and emotional distress 
symptoms occurring in patients with early stages melanoma in long-term follow-up, 25% and 
44%, respectively. What is more, psychological distress seems to be higher in women than in 
men, and in patients with a higher educational level. 
From a medical point of view, different disease severity means differences regarding long-
 term prognosis and follow-up implications [10]. Indeed, if 5 years’ survival ranges from 96% 
to 92% in Tis-Ia stages of melanoma, it decreases to 91-67% in Ib-II stages [3,4]. In addition, 
patients in Ib-II stages underwent more invasive surgery (such as sentinel lymph node 
biopsy) and were required to periodically perform more invasive medical screening 
(ultrasounds, X-ray, CT and RMI) which could contribute to enhanced psychological distress 
levels. Nevertheless, no significant differences between MP_Tis-Ia and MP_Ib-II were found 
in psychological distress variables. Patient group differences in psychological distress was 
not obscured by the sex differences. 
In fact, even if women were found to report higher levels of psychological distress and in 
spite of the difference in sex distribution, no differences in the mean levels of psychological 
distress had been found between female patients in Tis-Ia and female patients in Ib-II or 
between male patients in Tis-Ia and male patients in Ib-II. 
This result suggests that the underlying fear of disease recurrence/metastasis may be the main 
factor behind the increased prevalence of distress in patients attending their scheduled visit, 
independently of disease stage, as suggested by Loquai and colleagues [12]. 
One variable demonstrating a close relationship with psychological distress is coping ability. 
Melanoma patients in this sample adopted predominantly positive and active strategies, and 
this was associated with lower levels of psychological distress. Furthermore, in line with the 
literature [19], maladaptive responses as displayed through behavioral disengagement, denial, 
self-distraction and self-blame were most strongly related to increased levels of psychological 
distress. 
In conclusion, the main finding of the present study is that emotional distress is highly 
present in patients with early-stage melanoma, especially women, including at long-term 
follow-up. In addition, the psychological distress seems to be highly associated with a 
maladaptive coping style. These results highlight the need for regular psychological distress 
 screening in all phases of cancer care. 
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 Table 1. Socio-demographic and clinical data of the whole sample (T-Sample: N=204) 
and comparison between the MP_Tis-Ia (N=118) and the MP_Ib-II (N=86) groups. 
 T-Sample  MP_Tis-Ia  MP_Ib-II p 
Age (Mean (SD))a 53.1 (13.1) 52.9 (13.7) 53.3 (12.2) .84 
Age at diagnosis (Mean (SD))a 49.2 (13.0) 48.8 (13.5) 49.8 (12.4) .61 
Time since diagnosis (Mean (SD))b 46.8 (40.5) 49.8 (45.6) 42.7 (32.1) .99 
Gender  
N (%)c  
Male 96 (47.1%) 46 (39.0%) 50 (58.1%) 
.007 
Female 108 (52.9%) 72 (61.0%) 36 (41.9%) 
Educational level 
N (%)c 
Low/average 57 (28.1%) 31 (54.4%) 26 (45.6%) 
.56 
High 146 (71.9%) 86 (58.9%) 60 (41.1%) 
Work status  
N (%)c 
Employed 129 (63.2%) 73 (61.9%) 56 (65.1%) 
.63 
Unemployed 75 (36.8%) 45 (38.1%) 30 (34.9%) 
Marital status  
N (%)c 
Married 160 (78.4%) 93 (78.8%) 67 (77.9%) 
.88 




HADS-D  3.25 (3.1) 3.37 (3.2) 3.09 (3.1) .52 
HADS-A  5.00 (4.1) 5.16 (4.3) 4.77 (3.8) .66 





Positive reframing 5.82 (1.9) 5.86 (1.9) 5.75 (2.0) .73 
Self-distraction 4.60 (2.1) 4.58 (2.1) 4.62 (2.1) .95 
Expression 4.83 (1.8) 4.99 (1.8) 4.61 (1.7) .13 
Instrumental support 5.19 (1.9) 5.27 (2.0) 5.07 (1.8) .43 
Active coping 6.73 (1.7) 6.82 (1.5) 6.60 (1.9) .98 
Denial  2.72 (1.3) 2.74 (1.3) 2.69 (1.2) .64 
Religion  4.94 (2.2) 4.86 (2.2) 5.06 (2.2) .52 
Humour  4.16 (1.7) 4.20 (1.7) 4.09 (1.6) .64 
Behavioural-
disengagement 2.87 (1.3) 2.86 (1.2) 2.87 (1.4) .57 
Emotional support 4.53 (1.9) 4.83 (2.1) 4.11 (1.8) .015 
Use of alcohol/drugs 2.06 (0.5) 2.10 (0.6) 2.01 (0.1) .31 
Acceptance 7.02 (1.4) 6.99 (1.4) 7.06 (1.4) .75 
Planning 6.63 (1.8) 6.68 (1.6) 6.55 (1.9) .90 
Self-blame 5.22 (1.7) 5.33 (1.7) 5.07 (1.7) .23 
a T-test; b Mann-Whitney U-Test; c Chi-Square Test. 
HADS-D: depression subscale of the Hospital Anxiety and Depressive Scale;  
HADS-A: anxiety subscale of the Hospital Anxiety and Depressive Scale;  
DT: Distress Thermometer. 
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Table 2: Correlations between psychological distress variables and coping 
strategies.  
  HADS-D HADS-A DT 
Brief-
COPE 
Positive reframing -0.200* -0.141 -0.050 
Self-distraction 0.311** 0.363** 0.352** 
Expression 0.056 0.152 0.231* 
Instrumental support -0.042 0.071 0.029 
Active coping -0.085 -0.015 0.048 
Denial  0.249** 0.288** 0.163* 
Religion  0.044 0.107 -0.05 
Humour  -0.091 -0.046 -0.036 
Behavioural-disengagement 0.325** 0.217* 0.253** 
Emotional support 0.075 0.159 0.165 
Use of alcohol/drugs 0.098 0.089 0.137 
Acceptance -0.200* -0.176* -0.146 
Planning -0.187* -0.094 -0.003 
Self-blame 0.148 0.278** 0.184* 
* p<.017; ** p<.001 
Spearman’s correlation coefficients are listed.  
Brief-COPE: Coping Orientation to Problem Experiences Scale-brief version;  
HADS-D/-A: Hospital Anxiety and Depressive Scale – Depression/Anxiety subscale;  
DT: Distress Thermometer.  
 
